We’re pleased to share the good news from sister charity Brain Tumour Research’s Centre of Excellence at Plymouth University about their breakthrough in meningioma.
The Brain Tumour Research Campaign holds or participates in a number of fundraising events…
Buying items from our shop helps support the Brain Tumour Research Campaign…
Find out about all upcoming and recent events supporting Brain Tumour awareness and fundraising…
Research into brain tumours must not be left behind – the nation needs to invest at least £35 million a year if we are to find a cure for brain tumours in the next 20 years.
Find out moreOur partners, supporters and researchers are frequently featured in the newspapers, on radio and television – we are always keen to promote our work and raise awareness of the desperate plight of brain tumours patients and their families and friends.
Read about some people whose lives have been touched by brain tumours – we hope you feel as inspired by them as we do!
Diagnosed with a brain tumour at the age of 23, Anna Swabey was initially given just months to live, but under the care of consultant neurosurgeon Kevin O’Neill, at Imperial College, London, Anna had surgery and went on to have a year’s chemotherapy and radiotherapy under oncologist Matt Williams. She shared her experiences from the time of her diagnosis almost up to her death through her blog “Inside My Head”.
More than 12,000 people are diagnosed yearly with brain tumours. Many of these will also experience chronic pain. Fibromyalgia and arthritis are just two examples of this.
1.5 billion people around the globe are affected by chronic pain. Physical symptoms can be severe and mental health often gets pushed aside. So many people suffer from pain daily, and we must start looking at how to improve the mental impact.
Our brain tumour research programme is possibly one of the most comprehensive in the world. Its aim is to look at every possibility to improve the outlook for brain tumour patients by producing rapid “translational” research, ie research that translates into treatments as quickly as possible. We have examined every aspect of the patient pathway from diagnosis through treatment to survival and have identified areas that require improvement to achieve this.
